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a b s t r a c t
Reliability (precision, repeatability, agreement) and validity (accuracy) are two completely
different issues which should be assessed using appropriate tests. It is crucial to know that,
reporting concordance rate; the selection error rate and the classiﬁcation error rate are not
the most appropriate estimates to assess reliability. Regarding reliability, for qualitative
variables, weighted kappa should be used with caution. However, sensitivity, speciﬁcity,
positive predictive value (PPV), negative predictive value (NPV), likelihood ratio positive and
negative as well as diagnostic accuracy are estimates that are usually used to evaluate the
validity of a test compared to a gold standard.
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ScienceDirect
journal homepage: http://www.elsevier.com/locate/pjnnsI was interested to read the paper by Hernández Medrano I and
colleagues published in Neurologia 2017 Mar [1]. The mini-
mum basic dataset (MBDS) is the largest available hospital care
administrative database that is used in clinical studies and
hospital management in association with diagnosis-related
groups (DRGs). The authors aimed to assess the reliability of
MBDS which are referred to cerebrovascular disease (CVD).
Using all discharge reports from the Spanish MBDS in 2009, a
representative sample was obtained by stratiﬁed sampling and
11,209 records were evaluated. Outcome indicators were
obtained to measure any differences observed between the
national MBDS being evaluated and the hospital's original
MBDS. Analysis of codes for CVD as a primary diagnosis was
performed for ICD-9-CM diagnostic categories 430 through 438.
Based on their results, 397 discharges of cases of CVD which
included 21 different DRGs. Diagnostic coding showed a
concordance rate of 81.87%; the selection error rate was
2.26% and the classiﬁcation error rate was 15.87%. The error
rate in the DRG was 16.12% and associated with the greatest
impact on the mortality risk level. They concluded that the
quality of the MBDS for CVD is sufﬁcient to ensure delivery of
valid information [1].
First, reliability (precision, repeatability, agreement) and
validity (accuracy) are two completely different issues which
should be assessed using appropriate tests [2–7]. It is crucial toknow that, reporting concordance rate; the selection error rate
and the classiﬁcation error rate are not the most appropriate
estimates to assess reliability [2–7]. Regarding qualitative
variables, even applying kappa value can cause a misleading
message. Two important weaknesses of k statistics to assess
reliability are as follows: It depends upon the prevalence in
each category which means it can be possible to have
different kappa value having the same percentage for both
concordant and discordant cells (selection error rate and the
classiﬁcation error rate)! Kappa value also depends upon the
number of categories. In such situations, weighted kappa
should be applied with caution. Moreover, to assess the
validity (accuracy) of the MBDS; sensitivity, speciﬁcity, positive
predictive value (PPV), negative predictive value (NPV),
likelihood ratio positive and negative as well as diagnostic
accuracy are among well-known estimates [2–7].
Therefore, to correctly assess reliability or validity of the
MBDS, the above mentioned statistical and methodological
issue should be taken into account.
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